Guggenheim Capital’s Invacare Corporation IVC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-25,192
| Closed | -$120K | – | 2266 |
|
|
2021
Q3 | $120K | Sell |
25,192
-44,178
| -64% | -$323K | ﹤0.01% | 2104 |
|
|
2021
Q2 | $560K | Buy |
69,370
+27,892
| +67% | +$232K | ﹤0.01% | 1789 |
|
|
2021
Q1 | $333K | Buy |
41,478
+25,083
| +153% | +$234K | ﹤0.01% | 1915 |
|
|
2020
Q4 | $147K | Sell |
16,395
-5,176
| -24% | -$43K | ﹤0.01% | 1991 |
|
|
2020
Q3 | $162K | Buy |
21,571
+11,270
| +109% | +$78.1K | ﹤0.01% | 1821 |
|
|
2020
Q2 | $66K | Sell |
10,301
-128
| -1% | -$856 | ﹤0.01% | 1842 |
|
|
2020
Q1 | $77K | Sell |
10,429
-10,092
| -49% | -$78.2K | ﹤0.01% | 1771 |
|
|
2019
Q4 | $185K | Sell |
20,521
-14,253
| -41% | -$120K | ﹤0.01% | 2005 |
|
|
2019
Q3 | $261K | Buy |
34,774
+23,505
| +209% | +$132K | ﹤0.01% | 1906 |
|
|
2019
Q2 | $58K | Sell |
11,269
-4,481
| -28% | -$29.2K | ﹤0.01% | 2091 |
|
|
2019
Q1 | $132K | Buy |
15,750
+3,401
| +28% | +$24.5K | ﹤0.01% | 2126 |
|
|
2018
Q4 | $53K | Buy |
+12,349
| New | +$109K | ﹤0.01% | 2143 |
|
|
2018
Q2 | – | Sell |
-38,947
| Closed | -$679K | – | 2673 |
|
|
2018
Q1 | $679K | Sell |
38,947
-6,300
| -14% | -$111K | ﹤0.01% | 2263 |
|
|
2017
Q4 | $764K | Sell |
45,247
-181,199
| -80% | -$2.95M | ﹤0.01% | 2205 |
|
|
2017
Q3 | $3.57M | Buy |
226,446
+39,492
| +21% | +$564K | 0.01% | 1269 |
|
|
2017
Q2 | $2.47M | Sell |
186,954
-65,869
| -26% | -$866K | 0.01% | 1484 |
|
|
2017
Q1 | $3.01M | Sell |
252,823
-50,275
| -17% | -$603K | 0.01% | 1348 |
|
|
2016
Q4 | $3.96M | Buy |
303,098
+157,626
| +108% | +$1.81M | 0.01% | 1148 |
|
|
2016
Q3 | $1.63M | Sell |
145,472
-411
| -0.3% | -$4.95K | 0.01% | 1753 |
|
|
2016
Q2 | $1.77M | Buy |
145,883
+2,622
| +2% | +$30.9K | 0.01% | 1641 |
|
|
2016
Q1 | $1.89M | Buy |
143,261
+3,479
| +2% | +$49.3K | 0.01% | 1616 |
|
|
2015
Q4 | $2.43M | Sell |
139,782
-31,802
| -19% | -$574K | 0.01% | 1473 |
|
|
2015
Q3 | $2.48M | Sell |
171,584
-4,639
| -3% | -$81.2K | 0.01% | 1446 |
|
|
2015
Q2 | $3.81M | Sell |
176,223
-781
| -0.4% | -$16.5K | 0.01% | 1301 |
|
|
2015
Q1 | $3.44M | Sell |
177,004
-6,897
| -4% | -$119K | 0.01% | 1373 |
|
|
2014
Q4 | $3.08M | Buy |
183,901
+9,180
| +5% | +$139K | 0.01% | 1418 |
|
|
2014
Q3 | $2.06M | Sell |
174,721
-16,656
| -9% | -$254K | ﹤0.01% | 1747 |
|
|
2014
Q2 | $3.52M | Sell |
191,377
-9,417
| -5% | -$160K | 0.01% | 1398 |
|
|
2014
Q1 | $3.83M | Sell |
200,794
-7,421
| -4% | -$153K | 0.01% | 1295 |
|
|
2013
Q4 | $4.83M | Sell |
208,215
-17,623
| -8% | -$365K | 0.01% | 1108 |
|
|
2013
Q3 | $3.9M | Buy |
225,838
+6,621
| +3% | +$105K | 0.01% | 1221 |
|
|
2013
Q2 | $3.15M | Buy |
+219,217
| New | +$3.04M | 0.01% | 1281 |
|
Other funds holding IVC
RCM
Guggenheim Capital's IVC Position: Q4 2021 in Review
Guggenheim Capital sold out of Invacare Corporation (IVC) in Q4 2021, closing a stake of 25,192 shares — an estimated $120K sold.
Guggenheim Capital first reported a position in IVC in Q2 2013 and held it in 32 quarters. The position peaked at $4.83M in Q4 2013. 120 funds tracked by Wall St. Rank hold IVC as of Q4 2021.
- Guggenheim Capital reported no remaining Invacare Corporation position as of Q4 2021 after selling out during the quarter.
- Guggenheim Capital sold 25,192 Invacare Corporation shares in Q4 2021, an estimated $120K.
- Guggenheim Capital first reported a position in Invacare Corporation in Q2 2013 and held it in 32 quarters.
- Guggenheim Capital's Invacare Corporation position peaked at $4.83M in Q4 2013.
- 120 funds tracked by Wall St. Rank held Invacare Corporation as of Q4 2021.
Based on Guggenheim Capital's 13F filing for Q4 2021, filed 14 Feb 2022.